Advances in radioligand theranostics in oncology

Lawal, Ismaheel Opeyemi; Abubakar, Sofiullah O.; Ndlovu, Honest; Mokoala, Kgomotso M.G.; More, Stuart; Sathekge, Mike Machaba

dc.contributor.author	Lawal, Ismaheel Opeyemi
dc.contributor.author	Abubakar, Sofiullah O.
dc.contributor.author	Ndlovu, Honest
dc.contributor.author	Mokoala, Kgomotso M.G.
dc.contributor.author	More, Stuart
dc.contributor.author	Sathekge, Mike Machaba
dc.date.accessioned	2024-06-19T09:33:03Z
dc.date.issued	2024-05
dc.description.abstract	Please read abstract in the article.	en_US
dc.description.department	Nuclear Medicine	en_US
dc.description.embargo	2025-03-31
dc.description.librarian	hj2024	en_US
dc.description.sdg	SDG-03:Good heatlh and well-being	en_US
dc.description.uri	https://link.springer.com/journal/40291	en_US
dc.identifier.citation	Lawal, I.O., Abubakar, S.O., Ndlovu, H. et al. Advances in Radioligand Theranostics in Oncology. Molecular Diagnosis & Therapy 28, 265–289 (2024). https://doi.org/10.1007/s40291-024-00702-4.	en_US
dc.identifier.issn	1177-1062 (print)
dc.identifier.issn	1179-2000 (online)
dc.identifier.other	10.1007/s40291-024-00702-4
dc.identifier.uri	http://hdl.handle.net/2263/96534
dc.language.iso	en	en_US
dc.publisher	Springer	en_US
dc.rights	© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. The original publication is available at : https://link.springer.com/journal/40291.	en_US
dc.subject	Lutetium-177 DOTATATE (177Lu-DOTATATE)	en_US
dc.subject	Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA)	en_US
dc.subject	Fibroblast activation protein (FAP)	en_US
dc.subject	Chemokine receptor 4 (CXCR4)	en_US
dc.subject	Radioligand	en_US
dc.subject	Theranostics	en_US
dc.subject	Oncology	en_US
dc.subject	SDG-03: Good health and well-being	en_US
dc.title	Advances in radioligand theranostics in oncology	en_US
dc.type	Postprint Article	en_US